+1 Recommend
1 collections
      • Record: found
      • Abstract: found
      • Article: found

      14C and 35S-SO 4 Metabolism of Acid Glycosaminoglycans in Bovine Heart Valves

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.


          Bovine heart valves metabolize up to 96% of exogenous <sup>14</sup>C-glucose to lactate when incubated in vitro under appropriate conditions. Small proportions of the <sup>14</sup>C-radioactivity are incorporated into glycogen, glycosaminoglycans and lipids and are oxydized to <sup>14</sup>CO<sub>2</sub>. Difference between the valves of the left ventricle (aortic and mitral valve) and of the right ventricle (pulmonary and tricuspid valve) were found in the rate of glycolysis as well as in the collagen, glycogen and glycosaminoglycan content. The in vitro incorporation of [U-<sup>14</sup>C] glucose radioactivity into the total glycosaminoglycans resulted in a specific labelling of hyaluronic acid, dermatan sulfate and chondroitin sulfate, but the specific radioactivities of the individual glycosaminoglycans and their relative rates of biosynthesis differed markedly. The relative rates of biosynthesis were 2.9–7.6 for hyaluronate, 1.0 for dermatan sulfate and 0.26–0.59 for chondroitin sulfate. After labelling the sulfated glycosaminoglycans with <sup>35</sup>S-sulfate, the metabolic heterogeneity of dermatan sulfate and chondroitin sulfate was confirmed, but, in addition, heparan sulfate – not previously detected in heart valves – was identified as a third sulfated glycosaminoglycan. Chemical analyses of heparan sulfate revealed a sulfate/uronic ratio of 0.5; its relative amount was found to be 2–4% of the total glycosaminoglycans. Analogous chemical and metabolic data were obtained with chordae tendineae, except that a higher relative percentage of dermatan sulfate was found than in the corresponding heart valves.

          Related collections

          Author and article information

          J Vasc Res
          Journal of Vascular Research
          S. Karger AG
          18 September 2008
          : 10
          : 3
          : 129-141
          Institute of Physiological Chemistry, University of Münster, Münster
          157966 Angiologica 1973;10:129–141
          © 1973 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          Page count
          Pages: 13


          Comment on this article